Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HYDRA: Hydrochlorothiazide for Hypernatremia
NCT03658850Phase 2Unknown
- Sponsor
- Universidade de São Paulo
- Start
- Oct 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of hydrochlorothiazide in hypernatremia (2 arms), sponsored by Universidade de São Paulo. Primary endpoint: Hypernatremia correction at Day 3. Status: unknown.
02
Drugs
hydrochlorothiazide
03
Conditions
hypernatremia
Beyond the preview
Go deeper on NCT03658850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03658850.